Serdolect

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Sertindole 16mg

Disponible desde:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

Designación común internacional (DCI):

Sertindole 16 mg

Dosis:

16 mg

formulario farmacéutico:

Film coated tablet

Composición:

Active: Sertindole 16mg Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose Opadry pink 03B24027 (rose)

Unidades en paquete:

Blister pack, PVC/PVDC/Al, 20 tablets

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Lundbeck Pharmaceuticals Italy SpA

indicaciones terapéuticas:

Sertindole is indicated for the treatment of schizophrenia. Due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. Sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Resumen del producto:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al - 20 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 28 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 30 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 50 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 98 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 100 tablets - 60 months from date of manufacture stored at or below 25°C

Fecha de autorización:

2006-04-13